BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30297104)

  • 1. LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway.
    Liu Z; Yao Y; Huang S; Li L; Jiang B; Guo H; Lei W; Xiong J; Deng J
    Biochem Biophys Res Commun; 2018 Nov; 505(3):843-849. PubMed ID: 30297104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p.
    Wang H; Di X; Bi Y; Sun S; Wang T
    Bioengineered; 2021 Dec; 12(1):1791-1802. PubMed ID: 33975517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
    Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
    Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long intergenic non-protein coding RNA 662 accelerates the progression of gastric cancer through up-regulating centrosomal protein 55 by sponging microRNA-195-5p.
    Tao F; Qi L; Liu G
    Bioengineered; 2022 Feb; 13(2):3007-3018. PubMed ID: 35037833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of long intergenic non-coding RNA LINC00662 contributes to malignant growth of acute myeloid leukemia cells by upregulating ROCK1 via sponging microRNA-340-5p.
    Liu Y; Gao X; Tian X
    Eur J Pharmacol; 2019 Sep; 859():172535. PubMed ID: 31306637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
    Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
    Cheng L; Xing Z; Zhang P; Xu W
    Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
    Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
    J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CFIm25-regulated lncRNA acv3UTR promotes gastric tumorigenesis via miR-590-5p/YAP1 axis.
    Liu K; Wang BJ; Han W; Chi CH; Gu C; Wang Y; Fu X; Huang W; Liu Z; Song X
    Oncogene; 2020 Apr; 39(15):3075-3088. PubMed ID: 32066878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA SOX2OT contributes to gastric cancer progression by sponging miR-194-5p from AKT2.
    Qu F; Cao P
    Exp Cell Res; 2018 Aug; 369(2):187-196. PubMed ID: 29782828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00662 triggers malignant progression of chordoma by the activation of RNF144B via targeting miR-16-5p.
    Wang CB; Wang Y; Wang JJ; Guo XL
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1007-1022. PubMed ID: 32096180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA CASC21 exerts an oncogenic role in colorectal cancer through regulating miR-7-5p/YAP1 axis.
    Zheng Y; Nie P; Xu S
    Biomed Pharmacother; 2020 Jan; 121():109628. PubMed ID: 31731190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the β-catenin signaling pathway.
    Luo M; Lei R; Zhao Q; Shen Y; He Z; Xu J
    Int J Med Sci; 2024; 21(2):265-276. PubMed ID: 38169586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA LINC00662 Regulated Proliferation and Migration by Targeting miR-34a-5p/LMAN2L Axis in Glioma.
    Geng Y; Wu Y; Xu C; Li T; Zhang L
    Onco Targets Ther; 2020; 13():10161-10172. PubMed ID: 33116598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
    Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
    Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
    Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
    J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
    Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
    Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and mechanisms of long non-coding RNA LINC00662 in promoting the proliferation, migration, and angiogenesis of BGC-823 and HGC-27 cells and the subsequent effect on the progression of gastric cancer.
    Xia X; Zhang G; Wang T; Ji M
    J Physiol Pharmacol; 2022 Dec; 73(6):. PubMed ID: 37087562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.